Attached files
| file | filename |
|---|---|
| EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - NeuBase Therapeutics, Inc. | ex31-2.htm |
| EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - NeuBase Therapeutics, Inc. | ex31-1.htm |
| 10-K/A - AMENDMENT TO FORM10-K - NeuBase Therapeutics, Inc. | ohrp-10ka_093015.htm |
Ohr Pharmaceutical, Inc. 10-K/A
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Ohr Pharmaceutical, Inc.
New York, New York
We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-201368) of Ohr Pharmaceutical, Inc. of our report dated December 14, 2015, relating to the consolidated financial statements, and our report dated December 14, 2015 with respect to the effectiveness of internal control over financial reporting as of September 30, 2015, which reports appear in this Annual Report on Form 10-K for the fiscal year ended September 30, 2015.
| /s/ MaloneBailey, LLP | |
| www.malone-bailey.com | |
| Houston, Texas | |
| December 7, 2016 |